QunaSys

Name: QunaSys
Brand: QunaSys

Developing algorithms and software to maximize the potential of quantum computers

Est 2018|Valuation $47.4M|Raised $24.2M|7 Ref Customers

LinkedIn 3K|Web traffic 7K|FTEs 56|HQ Bunkyo-Ku, Tokyo Metropolis, JP

01Competitive Landscape

Narrative competitive analysis

Where QunaSys appears to provide differentiated capabilities: - Chemistry and materials specialization is evident in Qamuy, QURI Chemistry, and QURI Bench. - A multi-platform strategy with QURI SDK interfaces to multiple simulators and providers can reduce provider lock-in. - The consortium model indicates an ecosystem approach intended to coordinate learning, pilots, and joint research for industry participants. Where alternatives may offer advantages: - Integrated providers may provide clearer enterprise packaging, documented compliance artifacts, and procurement maturity. - Specialist commercial vendors may offer more productized UX and support models depending on the vendor. - Open-source-first organizations may prefer community stacks (for example, Qiskit, PennyLane) for transparency and control. Evidence of adoption trends: - Vendor announcements cite consortium membership and partnerships, but public documentation of scaled production deployments is limited.

	QunaSys	HQS Quantum Simulations	Quantinuum
Starting Price	Not publicly listed (Qamuy); QURI SDK is open-source	Not publicly listed	Not publicly listed (enterprise plans)
Typical use case fit	Enterprise R&D exploring quantum chemistry/materials workflows and readiness; teams using open-source SDKs (QURI)	Chemistry and pharmaceutical organizations evaluating quantum simulation software from a specialist vendor	Organizations seeking an integrated ecosystem (hardware, software, and services) with broader enterprise positioning
Key strengths	Domain focus on chemistry/materials, consortium model, and an open-source SDK with multi-backend integrations	Domain specialization and commercial focus on chemistry/pharma simulation	Integrated stack that combines hardware and software offerings and broader product suite
Key weaknesses	Limited public enterprise security/compliance documentation; limited third-party reviews; pricing opacity	Pricing and implementation details not always publicly transparent; less evident open-source orientation	Potential vendor lock-in and potentially higher enterprise cost and complexity

01Competitive Landscape

Narrative competitive analysis

Where QunaSys appears to provide differentiated capabilities:

Chemistry and materials specialization is evident in Qamuy, QURI Chemistry, and QURI Bench.
A multi-platform strategy with QURI SDK interfaces to multiple simulators and providers can reduce provider lock-in.
The consortium model indicates an ecosystem approach intended to coordinate learning, pilots, and joint research for industry participants.

Where alternatives may offer advantages:

Integrated providers may provide clearer enterprise packaging, documented compliance artifacts, and procurement maturity.
Specialist commercial vendors may offer more productized UX and support models depending on the vendor.
Open-source-first organizations may prefer community stacks (for example, Qiskit, PennyLane) for transparency and control.

Evidence of adoption trends:

Vendor announcements cite consortium membership and partnerships, but public documentation of scaled production deployments is limited.

	QunaSys	HQS Quantum Simulations	Quantinuum
Starting Price	Not publicly listed (Qamuy); QURI SDK is open-source	Not publicly listed	Not publicly listed (enterprise plans)
Typical use case fit	Enterprise R&D exploring quantum chemistry/materials workflows and readiness; teams using open-source SDKs (QURI)	Chemistry and pharmaceutical organizations evaluating quantum simulation software from a specialist vendor	Organizations seeking an integrated ecosystem (hardware, software, and services) with broader enterprise positioning
Key strengths	Domain focus on chemistry/materials, consortium model, and an open-source SDK with multi-backend integrations	Domain specialization and commercial focus on chemistry/pharma simulation	Integrated stack that combines hardware and software offerings and broader product suite
Key weaknesses	Limited public enterprise security/compliance documentation; limited third-party reviews; pricing opacity	Pricing and implementation details not always publicly transparent; less evident open-source orientation	Potential vendor lock-in and potentially higher enterprise cost and complexity

QunaSys

01Competitive Landscape

Narrative competitive analysis

02Market Map

01Competitive Landscape

Narrative competitive analysis

02Market Map